Periodic Reporting for period 1 - Opti-AAV (Towards a gene therapy for age-related macular degeneration (AMD))

Age-related macular degeneration (AMD) is the leading cause of irreversible central blindness in the world. The number of people with AMD is predicted to be 288 million by 2040, with an estimated 1 in 10 people over the age of 55 already showing early signs of the condition...